SCHEMBL5124686

SCHEMBL5124686

O=C(O)CCCCN(C1CC1)S(=O)(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
HTT P42858 1/20 0.42
MCOLN3 Q8TDD5 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
FABP4 P15090 1/20 0.36
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP11B2 P19099 1/20 0.35
TSHR P16473 1/20 0.35
CDC25A P30304 1/20 0.34
CDC25B P30305 1/20 0.34
SLC6A4 P31645 1/20 0.34
F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5125364 0.90 HTT (0.52) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL5114179 0.86 PSEN1 (0.44) RORCPSEN1PSEN2APH1BNCSTN
SCHEMBL5117999 0.82 BDKRB1 (0.42) RORCHTTMCOLN3MEN1KMT2A
SCHEMBL5115197 0.80 MCOLN3 (0.51) HTTMCOLN3FABP4CDC25ACDC25B
SCHEMBL14093595 0.80 MCOLN3 (0.42) RORCHTTMCOLN3ATMTDP1
SCHEMBL4030931 0.77 HTT (0.44) RORCHTTMEN1KMT2A
SCHEMBL6764162 0.77 RORC (0.41) RORCHTTMCOLN3MEN1KMT2A
SCHEMBL5111158 0.76 MCOLN3 (0.52) HTTMCOLN3MEN1KMT2AFABP4
SCHEMBL5110833 0.73 BDKRB1 (0.46) RORCCYP11B2F10BDKRB1
SCHEMBL3439979 0.73 MCOLN3 (0.55) HTTMCOLN3MEN1KMT2ABDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7361687-B2 Arylsulphonamide derivatives and methods of preparing LABORATOIRES FOURNIER SA (FR) 2008-04-22 US disclosed
US-20060084699-A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents LABORATOIRES FOURNIER SA (FR) 2006-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084699-A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents UGT1A1, UGT2B7, UGT1A6 RORC 129/4885PSEN1 4069/4885PSEN2 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.